Oral GLP-1 Pill Orforglipron Shows Weight Loss Success
Eli Lilly's oral GLP-1 drug Orforglipron offers needle-free weight management with significant results in Phase 3 trials. Discover how this tablet alternative works.
Eli Lilly's oral GLP-1 drug Orforglipron offers needle-free weight management with significant results in Phase 3 trials. Discover how this tablet alternative works.
Odisha government mandates oil boards in childcare centers to educate children about hidden fats in snacks. Learn how this initiative tackles rising obesity rates.
Chandigarh Citizens Foundation and administration organized a mental wellness workshop for 150+ stakeholders to combat rising suicide cases among schoolchildren. Learn about the initiatives.
A PGI lecture revealed an epidemic of undiagnosed lifestyle diseases in Chandigarh. Over 100 attendees learned how obesity and diabetes are driving heart disease. Act now to protect your health.
Groundbreaking UC Riverside research reveals how America's favorite cooking oil contributes to weight gain and metabolic disorders. Learn the science behind soybean oil's impact on your health.
India faces a severe mental healthcare gap with only 0.75 psychiatrists per 100,000 people. Discover the challenges and solutions in our comprehensive analysis of the mental health crisis.
A bariatric surgeon reveals 7 crucial signs that childhood weight issues may indicate serious health problems. Learn to spot early warnings for diabetes, heart issues, and joint problems.
Eli Lilly's daily pill orforglipron shows 12% weight loss in trials, potentially revolutionizing obesity treatment. Could this be the end of injections?
Leading bariatric specialists Dr. Todkar, Dr. Dukkipati & Dr. Garg share crucial insights on managing India's dual health crisis through early intervention & lifestyle changes. Act now for better health!
Experts warn of rising anxiety, screen addiction, and cyberbullying among Indian youth. Dr. Rajesh Sagar reveals 80-90% treatment gap. Learn the signs and solutions.
Childhood obesity in India surges from 3-4% to 8-9%, driven by lifestyle changes and mental health factors. Dr. Atul Peters reveals how families can reverse this alarming trend through simple changes.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
A new report reveals a sharp 5-fold increase in obesity in India over 30 years, affecting 1 in 4 adults. Learn about the health risks and what it means for the nation.
New Lancet study reveals 25% of Indians face obesity, costing economy ₹29,000 crore annually. Urgent public health action needed to address this growing crisis.
New OSSI survey reveals insurance barriers prevent timely obesity treatment in India. Learn how policy gaps affect patient care and what needs to change.
PGI Chandigarh warns of a sharp increase in Type 2 diabetes among children and young adults, driven by junk food and sedentary lifestyles. Learn how to prevent it.
Delhi Education Minister mandates schools to report mental health guideline compliance. Committee formed to investigate student welfare issues. Read the latest updates.
Lancet study reveals India's ultra-processed food epidemic with retail sales skyrocketing 40-fold since 2006, driving obesity and diabetes crisis among youth. Experts demand urgent policy reforms.
Discover the top 6 lifestyle diseases affecting Indians, their causes, symptoms, and preventive measures. Learn how to protect your health today!
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Connecting Trust marks 20 years with a 3-day international conference on suicide prevention in Pune. Mental health experts to share insights on building resilience and community support systems. Join the dialogue from November 28-30.
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Indian cricketer KL Rahul reveals his mental health journey, dealing with criticism, and finding balance beyond cricket in Humans of Bombay's new show.
Assam Police reports significant fitness improvement with only 2.06% of 73,317 personnel classified as obese in annual BMI tests. Discover how the force is getting leaner and mission-ready.
Dr. Vaishaly Bharambe explores social media's dual impact on mental health - from isolation to support groups. Learn how digital literacy can transform your online experience. Read now!
A 16-year-old Mumbai student reversed his Type 2 diabetes risk factors. Discover how an endocrinologist's plan involving diet, exercise, and family support led to a 7 kg weight loss and improved HbA1c levels in six months.
Arjun Kapoor speaks candidly about his mental health journey, starting therapy during lockdown, and overcoming obesity. Read his powerful message on strength.
A 36-year-old Chinese man died days after gastric bypass surgery he hoped would help him impress his girlfriend's parents. The tragedy sparks debate about weight-loss surgery risks.
Lancet study shows child hypertension doubled 2000-2020. 114 million affected globally. Obesity, poor diet, sedentary lifestyles identified as key triggers. Learn prevention strategies.
Novo Nordisk reduces Wegovy price by 37% in India, intensifying the weight loss drug war with Eli Lilly's Mounjaro. Discover the new costs and market impact.